Attached files
| file | filename |
|---|---|
| 8-K - CDEX INC | m2111038k.htm |
| EX-99.1 - PRESS RELEASE, DATED FEBRUARY 10, 2010 - CDEX INC | ex99_1.htm |
| EX-99.3 - CONSULTING AGREEMENT - CDEX INC | ex99_3.htm |
| EX-99.4 - CEO CORNER: WHAT'S NEW! - CDEX INC | ex99_4.htm |
EXHIBIT
99.2
CDEX INC
SEEKS COMMERCIALIZATION MANAGEMENT TEAM TO SUPPORT INCREASED SALES PROJECTIONS
FOR 2010
CDEX begins CEO search and
reorganization of Board of Directors.
Tucson, Arizona – February 11, 2010
– CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com)
announces that it is beginning a search for a new CEO with product
commercialization and public company experience to lead the company in the
expanding market climate of 2010 (see the new CEO Corner update and additional
information on the Company’s web site). In addition, Greg Firmbach
will join the Company’s Board of Directors.
“With the
upswing in ValiMed™ MVS units under contract and the need to look again at
increasing ValiMed™ production for 2010, I believe it is time to bring in a new
commercialization management team to take us to the next level,” said Malcolm
Philips, CDEX CEO. “Greg Firmbach, our new President, is the
cornerstone of that Team. To complement Greg’s strengths in sales and
marketing, we are beginning a search for a new CEO with outstanding product
commercialization and public company experience. While we already
have several candidates that have stepped forward, interested and qualified
persons should contact us.”
About
CDEX
CDEX
develops, manufactures and globally distributes products to the healthcare and
security markets. The ValiMed™ product line provides life-saving
validation of high-risk medications and returned narcotics. The ID2™
product line detects trace amounts of illegal drugs, such as
methamphetamine. CDEX expects to advance its patented technologies to
serve additional markets. To meet its plans, CDEX must strengthen its financial
position as stated periodically in its SEC filings. For more
information, contact Malcolm Philips at mphilips@cdex-inc.com.
Non-historical
statements are forward-looking, as defined in federal securities laws, and
generally can be identified by words such as "expects," "plans," "may,"
"believes," "should," "intends," and similar words. These statements pose risks
that cannot be accurately predicted. Consequently, results may differ
materially from those expressed or implied. Such risks and uncertainties
include, without limitation, the effectiveness, profitability and marketability
of products, the protection of intellectual property and proprietary
information, and other risks detailed periodically in filings with the SEC.
There is no obligation to update any forward-looking statements.
4555 S.
Palo Verde Rd. Suite 123 Tucson, AZ
85714 (520) 745-5172www.cdexinc.com